Five law firms representing 98 former NFL players now stand accused of scheming to defraud the league’s concussion settlement fund of more than $87 million. Special Masters David A. Hoffman and Jo-Ann M. Verrier laid out the findings in a 51-page decision made public this week.
The audit claims the firms worked with a small group of doctors to secure improper Parkinson’s disease diagnoses. Players then received powerful medications before their evaluations by physicians approved by the fund’s administrators. Fund doctors, the masters wrote, often trusted the outside paperwork even when the player in front of them showed few visible symptoms.
How the Alleged Scheme Worked
According to the special masters, the process created a dangerous shortcut. Players arrived at official evaluations already taking drugs such as Levodopa. That medication can quiet the tremors, stiffness, and other outward signs of Parkinson’s. The examining physicians then faced a patient who “looks well” but carried thick records and an active prescription.
“Faced with a patient who looks well but arrives with outside records describing prior complaints and an active prescription that has apparently masked them, [the doctor] defers to the paperwork,” Hoffman and Verrier wrote.
The decision does not claim any specific player lacks Parkinson’s. It targets only the process lawyers used to build and push the claims. Parkinson’s remains a progressive neurological disorder with no cure, and qualifying diagnoses carry significant weight under the settlement’s payout structure.
The Firms and the Stakes
The lawyers and firms named in the filing are:
- Douglas Grossinger
- Feder Law LLC
- Pro Athlete Law Firm PA
- Syme Law PLLC
- Reppert Oates & Vytell LLC
All five declined or did not respond to requests for comment. The special masters recommended that all pending claims tied to these firms — or evaluated by the eight doctors listed in the report — be denied. They also called for a complete remake of how Parkinson’s diagnoses are handled going forward inside the settlement program.
NFL Response and Broader Context
The NFL, which has already paid out more than $1.5 billion to former players through the uncapped fund, welcomed the decision.
“The remedies that the Special Masters imposed are provided for by the Settlement Agreement and were necessary given the scope of misconduct uncovered by the Claims Administrator’s investigation,” NFL spokesperson Brian McCarthy said. “We are hopeful that this decision will deter future misconduct.”
The concussion settlement grew out of the league’s 2013 agreement to resolve lawsuits from retired players who argued the NFL failed to act on mounting evidence about the long-term dangers of repeated head trauma. The fund was designed to run for 65 years and pay valid claims in full, without a cap. It has faced ongoing criticism from players and advocates over slow processing times and strict qualifying standards.
In 2021, after two former players sued, the NFL agreed to stop using “race-norming” in cognitive testing for dementia claims — a practice that had made it harder for Black players to qualify.
Not the First Red Flag
Hoffman has dealt with fraud concerns inside the program before. In 2021 he co-authored findings against a Florida firm accused of influencing doctors and forging medical records on behalf of players. That earlier case led to audits of hundreds of claims and referrals for further review.
The current decision stops short of a criminal finding. The special masters noted they retain the authority to refer their conclusions to federal authorities if they choose.
Why This Matters for Players
Retired players who gave their bodies to the game often carry lasting neurological issues that surface years or decades later. The settlement was meant to deliver some measure of support when those problems appear. When the claims process itself comes under fire, it raises hard questions about whether every dollar reaches the people it was built to help.
The special masters’ call to overhaul the Parkinson’s diagnostic pathway aims to close the exact gap the audit exposed: too much reliance on outside records and symptom-masking prescriptions, and not enough independent verification at the point of official evaluation.
For the thousands of former players who have already received compensation, and for those still waiting, the message from the court-appointed overseers is clear. The system that protects the fund’s integrity also protects the players who legitimately need it most.
